Accessibility settings

Published on in Vol 9 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/77621, first published .
Measuring FVIII Activity and Thrombin Generation Simultaneously With a Novel Point of Care Platform (EnzySystem HemA): Qualitative Usability Evaluation

Measuring FVIII Activity and Thrombin Generation Simultaneously With a Novel Point of Care Platform (EnzySystem HemA): Qualitative Usability Evaluation

Measuring FVIII Activity and Thrombin Generation Simultaneously With a Novel Point of Care Platform (EnzySystem HemA): Qualitative Usability Evaluation

Journals

  1. Bowyer A, Montalvão S, Dargaud Y. Practical Advances in the Diagnosis of Haemophilia and von Willebrand Disease Including Monitoring of Non‐Factor Replacement Therapies. Haemophilia 2026 View